Matches in SemOpenAlex for { <https://semopenalex.org/work/W3151650491> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W3151650491 abstract "Abstract Background : Toll-like receptor 4 (TLR4) is involved in the pathogenesis of arthritic diseases. The TLR4 inhibitor TAK-242 has shown potential as a possible treatment for rheumatoid arthritis in an adjuvant-induced arthritis rat model. However, further investigation of the anti-arthritis effect of TAK-242 in other animal models of arthritis disease is required. Objective : This study was conducted to examine the anti-arthritic effects and mechanisms of TAK-242 on curdlan-induced spondyloarthritis in SKG mice. Methods : Curdlan-injected SKG ZAP-70 W163C mice were intraperitoneally administered with TAK-242 (3 mg/kg) every other day or anti-IL-23 antibody (100 μg) weekly for 9 weeks. The therapeutic effect of TAK-242 was evaluated in the SKG mice by measuring the inflammation level of foot, ileum, lung and tail by histology, the levels of proinflammatory cytokines in serum, bone mineral density (BMD) in femur and spine, and CD4+T cell subtypes Th1 and Th17 in spleen. Results: TAK-242 treatment significantly reduced clinical score, paw width, and colon length in SKG mice. Consistent with the therapeutic effect, TAK-242 also reduced peripheral arthritis and IL-17 expression in the foot and ileum tissues. It also inhibited inflammation of the lungs, ileum, paws, and tail and reduced serum levels of pro-inflammatory cytokines such as IL-6 and TNF-α. TAK-242 recovered the reduced bone density in the femur but not in the spine. Treatment with TAK-242 also suppressed the populations of Th1 and Th17 cells in the spleen of SKG mice. Conclusions: TAK-242 may show beneficial anti-arthritis effects by inhibiting the proliferation of pro-inflammatory Th1 and Th17 cells. Further research is needed for TAK-242 to be repositioned as a treatment for arthritis disease." @default.
- W3151650491 created "2021-04-13" @default.
- W3151650491 creator A5019886336 @default.
- W3151650491 creator A5023107984 @default.
- W3151650491 creator A5030395754 @default.
- W3151650491 creator A5041502481 @default.
- W3151650491 creator A5090892663 @default.
- W3151650491 date "2021-01-29" @default.
- W3151650491 modified "2023-09-27" @default.
- W3151650491 title "Anti-Arthritic Effect of TLR4 Inhibitor TAK-242 Through the Inhibition of Th1 and Th17 Cell Proliferation in a Curdlan-Induced Spondyloarthritis SKG Mouse Model" @default.
- W3151650491 doi "https://doi.org/10.21203/rs.3.rs-156812/v1" @default.
- W3151650491 hasPublicationYear "2021" @default.
- W3151650491 type Work @default.
- W3151650491 sameAs 3151650491 @default.
- W3151650491 citedByCount "0" @default.
- W3151650491 crossrefType "posted-content" @default.
- W3151650491 hasAuthorship W3151650491A5019886336 @default.
- W3151650491 hasAuthorship W3151650491A5023107984 @default.
- W3151650491 hasAuthorship W3151650491A5030395754 @default.
- W3151650491 hasAuthorship W3151650491A5041502481 @default.
- W3151650491 hasAuthorship W3151650491A5090892663 @default.
- W3151650491 hasBestOaLocation W31516504911 @default.
- W3151650491 hasConcept C102652120 @default.
- W3151650491 hasConcept C126322002 @default.
- W3151650491 hasConcept C164027704 @default.
- W3151650491 hasConcept C203014093 @default.
- W3151650491 hasConcept C2776070231 @default.
- W3151650491 hasConcept C2776914184 @default.
- W3151650491 hasConcept C2777077863 @default.
- W3151650491 hasConcept C2777575956 @default.
- W3151650491 hasConcept C2780931953 @default.
- W3151650491 hasConcept C2780942790 @default.
- W3151650491 hasConcept C71924100 @default.
- W3151650491 hasConcept C98274493 @default.
- W3151650491 hasConceptScore W3151650491C102652120 @default.
- W3151650491 hasConceptScore W3151650491C126322002 @default.
- W3151650491 hasConceptScore W3151650491C164027704 @default.
- W3151650491 hasConceptScore W3151650491C203014093 @default.
- W3151650491 hasConceptScore W3151650491C2776070231 @default.
- W3151650491 hasConceptScore W3151650491C2776914184 @default.
- W3151650491 hasConceptScore W3151650491C2777077863 @default.
- W3151650491 hasConceptScore W3151650491C2777575956 @default.
- W3151650491 hasConceptScore W3151650491C2780931953 @default.
- W3151650491 hasConceptScore W3151650491C2780942790 @default.
- W3151650491 hasConceptScore W3151650491C71924100 @default.
- W3151650491 hasConceptScore W3151650491C98274493 @default.
- W3151650491 hasLocation W31516504911 @default.
- W3151650491 hasOpenAccess W3151650491 @default.
- W3151650491 hasPrimaryLocation W31516504911 @default.
- W3151650491 hasRelatedWork W1513368991 @default.
- W3151650491 hasRelatedWork W1986486552 @default.
- W3151650491 hasRelatedWork W2135038492 @default.
- W3151650491 hasRelatedWork W2136469540 @default.
- W3151650491 hasRelatedWork W2324261047 @default.
- W3151650491 hasRelatedWork W2340014349 @default.
- W3151650491 hasRelatedWork W2373757429 @default.
- W3151650491 hasRelatedWork W4241335203 @default.
- W3151650491 hasRelatedWork W4248746885 @default.
- W3151650491 hasRelatedWork W4290989979 @default.
- W3151650491 isParatext "false" @default.
- W3151650491 isRetracted "false" @default.
- W3151650491 magId "3151650491" @default.
- W3151650491 workType "article" @default.